Tarp S,Bartels EM,Bliddal H,et al.Effect of nonsteroidal antiinflammatory drugs on the C-reactive protein level in rheumatoid arthritis:a meta-analysis of randomized controlled trials[J].Arthritis Rheum,2012,64(11):3511-3521.
[2]
Jastrzαbek R,Straburzy？ska-Lupa A,Rutkowski R,et al.Effects of different local cryotherapies on systemic levels of TNF-α,IL-6,and clinical parameters in activerheumatoid arthritis[J].Rheumatol Int,2013,33(8):2053-2060.
Arinzon Z,Peisakh A,Schrire S,et al.C-reactive protein(CRP):an important diagnostic and prognostic tool in nursing-home-associatedpneumonia[J].Arch Gerontol Geriatr,2011,53(3):364-369.
Shimamoto K,Ito T,Ozaki Y,et al.Serum interleukin 6 before and after therapy with tocilizumab is a principal biomarker in patients with rheumatoid arthritis[J].J Rheumatol,2013,40(7):1074-1081.
[7]
Zhao MS,Xia RH,Wang YH,et al.Characteristics of vascular morphology and vascular endothelial growth factor in patients with osteoarthritis and rheumatoid arthritis[J].Beijing Da Xue Xue Bao,2012,44(6):927-931.
Knudsen LS,Hetland ML,Johansen JS,et al.Changes in plasma IL-6,plasma VEGF and serum YKL-40 during treatment with etanercept and methotrexate or etanercept alone in Patients with active rheumatoid arthritis despite methotrexate therapy[J].Biomark Insights,2009,4:91-95.
